News | December 06, 2024
Eugia Pharma receives USFDA approval for Pazopanib Tablets, 200 mg
The approved product has an estimated market size of US$ 106 million for the twelve months ending October 2024, according to IQVIA
The approved product has an estimated market size of US$ 106 million for the twelve months ending October 2024, according to IQVIA
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
The product will be marketed by Dr. Reddy's
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Donation drive in São Paulo aims to support 250 young women’s health and environmental responsibility
We are witnessing a steady and sustainable growth in the country as the Q2 revenue from operations increased by 31%
Pharma CDMO business has posted a 40% YoY in Q2 driven by BD efforts and backed by macro tailwinds
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
Subscribe To Our Newsletter & Stay Updated
